ACS Laboratory Announces New THCOa Safety Bundle

1.6 min readPublished On: January 19th, 2022By

BOCA RATON, Fla. – ACS Laboratory, hemp and cannabis testing facility in the eastern U.S., has developed the THCOa Safety Bundle Test, a testing panel to test for THC-O Acetate (THCOa), acetic anhydride and other specific cannabinoids. With the THCOa Safety Bundle, ACS Laboratory, a DEA-licensed laboratory, now tests for a total of 22 cannabinoids, more than any other cannabis or hemp lab in the U.S.

Following the excitement of Delta-8 THC and Delta-10 THC, THCOa has recently been gaining attention. An acetylated form of THC, THCOa does not naturally occur in hemp or cannabis plants. To create it, chemical reactants, as well as a catalyst, are needed (it can be produced from Delta-8 and Delta-9 THC).

“When creating our THCOa Safety Bundle, we not only took the time to create a method for THCOa, but also a method for the potential harmful chemical, acetic anhydride, that is used as a reactor – to ensure safety and purity for the consumer and for ACS Laboratory to continue to be a good corporate citizen,” said Roger Brown, president of ACS Laboratory. “Although there is excitement surrounding this cannabinoid, safety is our main priority and we strongly encourage suppliers to test beyond potency to ensure safety.”

An ISO 17025 accredited, DEA licensed, and CLIA licensed accredited laboratory, ACS Laboratory offers the largest state-of-the-art testing facility in cannabis and hemp testing in the eastern U.S. It is on a mission to support cannabis companies in their pursuit to deliver clean, safe, and innovative products that promote positive progress in the industry. ACS Laboratory is always ahead of the development curve, continually enhancing its testing methodologies and developing new tests for harmful toxins and therapeutic terpenes, and minor cannabinoids.

(This information is primarily sourced from ACS Laboratory.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • MariMed Inc.

MariMed Strengthens Executive Leadership Team

May 12th, 2022|

NORWOOD, Mass. - MariMed Inc. (OTCQX: MRMD), a multi-state cannabis operator focused on improving lives every day, today announced the appointment of Jon Levine to the new role of Chief Administration Officer and the appointment ...